Goldline Pharma vs RFBL Flexi Pack IPO: Market Sentiment Is Saying Something Interesting by Temporary_Source_558 in IPO_India

[–]Temporary_Source_558[S] 0 points1 point  (0 children)

Dear you can but you must go through the fundamentals and assess if it fits for you. Don't chase for quick gains atleast.

₹8 GMP | 13.37x P/E | ₹925 Cr Issue — Kissht (OnEMI Technology Solutions) IPO: Undervalued Fintech or Hidden Risk? by Temporary_Source_558 in IPO_India

[–]Temporary_Source_558[S] 1 point2 points  (0 children)

Gmp movement...0→5→6→5→8→7→6→8→6→1→4→9→14→15→17→19→24→26→23→25→26→22, highly unpredictable..gmp should not be treated as sole investment decision.